Medtech company Catalyst OrthoScience has received $15 million in equity and debt financing.
The additional funding allows Catalyst to strengthen its balance sheet and advance its commercial and clinical programs, according to an Oct. 22 news release from the company.
The financing round was led by RC Capital, with participation from Mutual Capital Partners, Derace Schaffer, MD, and Western Alliance Bank.
In addition, Theodore Blaine, MD, an orthopedic surgeon at HSS, has been appointed to Catalyst’s board of directors, the release said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
